A research team led by Minyoung Lee and Sunggyu Park of The Korea Institute of Materials Science (KIMS) Bio & Health ...
The total number of petitions for inter partes review (IPR) at the Patent Trial and Appeal Board (PTAB) has plummeted over ...
StockStory.org on MSN
Life sciences tools & services stocks Q1 results: Benchmarking 10x Genomics (NASDAQ:TXG)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and ...
As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
The U.S. Aptamers Market is projected to grow from USD 1.49 Billion in 2025 to USD 11.90 Billion by 2035, while Europe is ...
Researchers from the Cancer Science Institute of Singapore (CSI Singapore) at NUS have developed a new method that allows ...
A new intranasal DNA vaccine may give the immune system an extra weapon against tuberculosis by targeting bacteria that can ...
2don MSN
Gene-edited babies are now closer to becoming a reality. The ethical debate is far from settled
New research shows it’s possible to edit the DNA of human embryos with more precision. But scientists warn it’s still not ...
New research could help make future mRNA vaccines easier to store and distribute. The study, involving RMIT University, the ...
The pharmacogenomic testing service market is witnessing strong growth, driven by the increasing adoption of personalized medicine and the growing recognition of genetic factors in drug response.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results